60.49
前日終値:
$58.55
開ける:
$58.55
24時間の取引高:
3.33M
Relative Volume:
2.99
時価総額:
$4.83B
収益:
$541.74M
当期純損益:
$88.01M
株価収益率:
55.69
EPS:
1.0862
ネットキャッシュフロー:
$155.34M
1週間 パフォーマンス:
+12.79%
1か月 パフォーマンス:
+36.82%
6か月 パフォーマンス:
+42.36%
1年 パフォーマンス:
+125.62%
Veracyte Inc Stock (VCYT) Company Profile
名前
Veracyte Inc
セクター
電話
(650) 243-6300
住所
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
VCYT
Veracyte Inc
|
60.49 | 4.67B | 541.74M | 88.01M | 155.34M | 1.0862 |
|
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
|
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
|
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Underweight |
| 2025-10-20 | 開始されました | Canaccord Genuity | Hold |
| 2025-03-20 | 開始されました | Craig Hallum | Buy |
| 2024-12-05 | ダウングレード | Goldman | Buy → Neutral |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-10-16 | 開始されました | UBS | Buy |
| 2024-10-10 | 開始されました | Guggenheim | Buy |
| 2024-02-23 | 繰り返されました | Needham | Buy |
| 2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-07 | 開始されました | Stephens | Overweight |
| 2021-11-18 | 再開されました | Goldman | Buy |
| 2021-06-15 | 開始されました | Raymond James | Outperform |
| 2021-02-18 | 再開されました | Needham | Buy |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 開始されました | Morgan Stanley | Underweight |
| 2019-07-31 | 開始されました | Lake Street | Buy |
| 2019-07-02 | 開始されました | Needham | Buy |
| 2018-11-29 | ダウングレード | Janney | Buy → Neutral |
| 2018-10-31 | アップグレード | Janney | Neutral → Buy |
| 2017-11-07 | ダウングレード | Janney | Buy → Neutral |
| 2017-11-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 再開されました | BTIG Research | Buy |
| 2016-11-14 | 再開されました | Leerink Partners | Outperform |
| 2015-12-18 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-06-11 | 繰り返されました | Leerink Partners | Outperform |
| 2013-11-26 | 開始されました | William Blair | Outperform |
すべてを表示
Veracyte Inc (VCYT) 最新ニュース
Price to book forward of Veracyte, Inc. – FWB:12V - TradingView
Enterprise value to EBITDA forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally - Yahoo Finance
Veracyte, Inc. Actuals & Estimates (TRADEGATE:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (MUN:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (DUS:12V) - TradingView
Q1 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q4 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q2 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q3 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Veracyte, Inc. Actuals & Estimates (NASDAQ:VCYT) - TradingView
Veracyte Inc (VCYT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VCYT Forecast — Price Target — Prediction for 2027 - TradingView
12V Forecast — Price Target — Prediction for 2027 - TradingView
Veracyte Inc (VCYT) Shares Surge 3.1% -- What GF Score of 75 Tel - GuruFocus
Veracyte Jumps 7.2% Amid Sector-Wide Rally - AlphaStreet
Veracyte stock hits 52-week high at 55.32 USD - Investing.com
Veracyte stock hits 52-week high at 55.32 USD By Investing.com - Investing.com Canada
Insider Sell Alert: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Form 4 Veracyte Inc For: 22 June By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock - Investing.com
Veracyte (VCYT) director logs 3,729-share Rule 10b5-1 stock sale - Stock Titan
VCYT News | VERACYTE INC (NASDAQ:VCYT) - ChartMill
[144] VERACYTE, INC. SEC Filing - Stock Titan
VCYT|Veracyte Inc|Price:53.630|Chg%:2.34 - TradingKey
Veracyte Inc (VCYT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Veracyte Inc (VCYT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Veracyte Inc (VCYT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Veracyte Inc (VCYT) Institutional Confidence - TradingKey
Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Veracyte Inc (VCYT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Veracyte stock hits 52-week high at 50.81 USD By Investing.com - Investing.com South Africa
Is Veracyte Inc (VCYT) Overvalued After 3.5% Rally? GF Value Say - GuruFocus
Veracyte stock hits 52-week high at 50.81 USD - Investing.com
High Growth Momentum Breakout Setup: Veracyte Inc (NASDAQ:VCYT) - ChartMill
Veracyte (VCYT) director Jens Holstein awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Eliav Barr receives 5,272 restricted stock units - Stock Titan
Director at Veracyte (VCYT) receives grant of 5,272 restricted stock units - Stock Titan
Evan Jones of Veracyte (NASDAQ: VCYT) receives 5,272 restricted stock units - Stock Titan
Director at VERACYTE, INC. (VCYT) awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Robert Epstein receives 5,272-share RSU grant - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) director awarded 5,272 RSUs vesting over one year - Stock Titan
Veracyte, Inc. 2023 Equity Incentive Plan Amended – SEC 8-K Filing Details and Company Information - Minichart
Veracyte shareholders endorse board, pay and incentive plans - The Globe and Mail
FMR LLC's Strategic Acquisition of Veracyte Inc Shares - GuruFocus
Veracyte (VCYT) investors back 3.5M-share equity plan increase and elect full board - Stock Titan
Veracyte (NASDAQ:VCYT) Hits New 12-Month HighHere's Why - MarketBeat
Veracyte Inc (VCYT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):